US Patent Issued to Brown University on Aug. 19 for "Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive features" (Rhode Island Inventor)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,436, issued on Aug. 19, was assigned to Brown University (Providence, R.I.).

"Mutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive features" was invented by Eric M. Morrow (Barrington, R.I.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compounds and methods for treating a genetic disorder in childhood resulting from a mutation in the gene for the enzyme glutamate pyruvate transaminase 2 (gpt2). The mutation is a signature of metabolic defects."

The patent was filed on May 17, 2021, under Application No. 17/322,497.

*For further information, including ...